BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 4694690)

  • 1. Comparative study of the absorption, plasma levels, and urinary excretion of the "new" and the "old" Lanoxin.
    Falch D; Teien A; Bjerkelund CJ
    Br Med J; 1973 Mar; 1(5855):695-7. PubMed ID: 4694690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological availability of digoxin from Lanoxin produced in the United Kingdom.
    Johnson BF; Fowle AS; Lader S; Fox J; Munro-Faure AD
    Br Med J; 1973 Nov; 4(5888):323-6. PubMed ID: 4758424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The comparative bioavailability of Lanoxin tablets and Lanoxicaps with and without sorbitol.
    O'Grady J; Johnson BF; Bye C; French J
    Eur J Clin Pharmacol; 1978 Dec; 14(5):357-60. PubMed ID: 729628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The comparability of dosage regimens of Lanoxin tablets and Lanoxicaps.
    Johnson BF; Smith G; French J
    Br J Clin Pharmacol; 1977 Apr; 4(2):209-11. PubMed ID: 861135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variability of steady-state digoxin kinetics during administration of tablets or capsules.
    Johnson BF; Lindenbaum J; Budnitz E; Marwaha R
    Clin Pharmacol Ther; 1986 Mar; 39(3):306-12. PubMed ID: 3948469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maximal bioavailability of digoxin from tablets and oral solution in steady state.
    Manninen V; Reissell P; Ojala K
    Acta Med Scand; 1976; 199(6):487-9. PubMed ID: 937075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of steady-state serum concentrations of digoxin in tablets (Lanoxin) and capsules (Lanoxicaps) in the elderly.
    Pouwels MJ; Hooymans PM; van der Aa GC; Gribnau FW
    DICP; 1991 Oct; 25(10):1043-6. PubMed ID: 1803786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical study of the biological availability of lanatoside C and digoxin in long-term tests].
    Bodem G; Ochs H; Hahn E; Dengler HJ
    Schweiz Med Wochenschr; 1977 May; 107(19):658-66. PubMed ID: 867012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between plasma concentration and dose of digoxin in patients with and without renal impairment.
    Okada RD; Hager WD; Graves PE; Mayersohn M; Perrier DG; Marcus FI
    Circulation; 1978 Dec; 58(6):1196-203. PubMed ID: 709776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of high-dose cancer chemotherapy on the absorption of digoxin in two different formulations.
    Bjornsson TD; Huang AT; Roth P; Jacob DS; Christenson R
    Clin Pharmacol Ther; 1986 Jan; 39(1):25-8. PubMed ID: 3943266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioavailability studies with Digoxin-Sandoz and Lanoxin.
    Beveridge T; Kalberer F; Nüesch E; Schmidt R
    Eur J Clin Pharmacol; 1975 Jun; 8(5):371-6. PubMed ID: 1243983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A completely absorbed oral preparation of digoxin.
    Johnson BF; Bye C; Jones G; Sabey GA
    Clin Pharmacol Ther; 1976 Jun; 19(6):746-51. PubMed ID: 1269214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum-digoxin concentrations with a new digoxin derivative, beta-methyl-digoxin.
    Härtel G; Manninen V; Melin J; Apajalahti A
    Ann Clin Res; 1973 Apr; 5(2):87-90. PubMed ID: 4748756
    [No Abstract]   [Full Text] [Related]  

  • 14. Transition from Lanoxin capsules to Lanoxin tablets in the debilitated elderly.
    Drinka PJ; Nickel DA; Schomisch GW; Depka CH; Deterville RJ
    DICP; 1990 Apr; 24(4):381-2. PubMed ID: 2327116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of digoxin particle size on absorption of digoxin and the effect of propantheline and metoclopramide.
    Johnson BF; O'Grady J; Bye C
    Br J Clin Pharmacol; 1978 May; 5(5):465-7. PubMed ID: 656287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maximal intestinal absorption of digoxin, and its relation to steady state plasma concentration.
    Johnson BF; Bye C
    Br Heart J; 1975 Feb; 37(2):203-8. PubMed ID: 1091283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absorption of digoxin from a new microencapsulated formulation.
    Bergdahl B; Bogentoft C; Jonsson UE; Magnusson JO
    Eur J Clin Pharmacol; 1980 Jun; 17(6):443-7. PubMed ID: 7398735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of a standard breakfast on digoxin absorption in normal subjects.
    Johnson BF; O'Grady J; Sabey GA; Bye C
    Clin Pharmacol Ther; 1978 Mar; 23(3):315-9. PubMed ID: 627138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent changes in biological availability of digoxin. Effect of an alteration in 'Lanoxin' tablets.
    Shaw TR; Howard MR; Hamer J
    Br Heart J; 1974 Jan; 36(1):85-9. PubMed ID: 4818143
    [No Abstract]   [Full Text] [Related]  

  • 20. Bioavailability of drugs: the digoxin dilemma.
    Greenblatt DJ; Smith TW; Koch-Weser J
    Clin Pharmacokinet; 1976; 1(1):36-51. PubMed ID: 797491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.